transcatheter mitral valve

Resultados alentadores en la válvula mitral percutánea en los pacientes complejos

Severe Mitral Regurgitation and Cardiogenic Shock: Is Edge-to-Edge a Valid Strategy?

At present, cardiogenic shock continues to present high mortality despite the new treatments and ventricular assistance devices available in some centers.&nbsp; In this group, the presence of severe mitral regurgitation (MR) is around 5% and, on many occasions, it cannot be treated with surgery because of hemodynamic conditions.&nbsp; Edge-to-edge repair has been looked at by<a href="https://solaci.org/en/2022/11/30/severe-mitral-regurgitation-and-cardiogenic-shock-is-edge-to-edge-a-valid-strategy/" title="Read more" >...</a>

¿Qué usar para medir funcionalmente una lesión coronaria en el contexto de estenosis aórtica severa?

Edge-to-Edge Repair Reduces Hospitalization and Mortality Rates in Secondary Mitral Valve Regurgitation?

Severe secondary mitral valve regurgitation is associated to hospitalization and mortality.&nbsp; The COAPT study has shown the superiority of guideline directed medical therapy at maximal tolerated doses according to guidelines (GDMT) plus edge-to-edge transcatheter repair (TEER) versus GMDT alone. However, at present there is no information on the impact of hospitalizations and their relationship to<a href="https://solaci.org/en/2022/11/22/edge-to-edge-repair-reduces-hospitalization-and-mortality-rates-in-secondary-mitral-valve-regurgitation/" title="Read more" >...</a>

La insuficiencia renal post tratamiento borde a borde tricuspídeo impacta en el pronóstico

Prognostic Impact of Acute Kidney Injury Following Tricuspid Transcatheter Edge-to-Edge Repair

Tricuspid failure (TF) mostly affects the elderly and, because of this, is associated with comorbidities that increase surgical risk.&nbsp; Tricuspid edge to edge repair (TEER) has surged as a valid alternative for the mitral valve in high-risk patients and, at present, is increasingly being used for tricuspids.&nbsp; One of the complications following TEER is acute<a href="https://solaci.org/en/2022/10/12/prognostic-impact-of-acute-kidney-injury-following-tricuspid-transcatheter-edge-to-edge-repair/" title="Read more" >...</a>

TCT 2022

TCT 2022 | CLASP II D TRIAL: Transcatheter Edge-to-Edge Repair for Mitral Regurgitation in Patients at Prohibitive Risk

The CLASP IID study was a prospective randomized study to assess the efficacy and effectiveness of the PASCAL transcatheter valve repair system compared with the MitraClip device for patients with degenerative mitral regurgitation (MR) at prohibitive surgical risk. The study included Patients at prohibitive surgical risk, candidates for both devices, with MR 3+ to 4+,<a href="https://solaci.org/en/2022/09/21/tct-2022-clasp-ii-d-trial-transcatheter-edge-to-edge-repair-for-mitral-regurgitation-in-patients-at-prohibitive-risk/" title="Read more" >...</a>

Resultados alentadores en la válvula mitral percutánea en los pacientes complejos

Is the Cause of Mitral Regurgitation Relevant for MitraClip?

Mitral regurgitation (MR) is the most common valvulopathy: it is present in (at least) 7.5% of patients &gt;75&nbsp;years old. This pathology can be classified as primary or degenerative MR (DMR) and secondary or functional MR (FMR). &nbsp; FMR can be caused by dilatation of the left atrium (most often due to atrial fibrillation), occurring in<a href="https://solaci.org/en/2022/09/16/is-the-cause-of-mitral-regurgitation-relevant-for-mitraclip/" title="Read more" >...</a>

SOLACI-SOCIME 2022 &#8211; MITRAL VALVE Session

&#x2714;&#xfe0f; MITRAL VALVE Session &#x2714;&#xfe0f; SOLACI-SOCIME 2022 Scientific Session &#x1f468;&#x200d;&#x1f3eb; Content: 00:07 &#8211; Welcoming Words- Dr. Guering Eid Lidt (MEX) 01:26 &#8211; Mitral valve replacement &#8211; Dr. Ignacio Amat (ESP) 18:15 &#8211; Transcatheter treatment of mitral valve regurgitation &#8211; Dr. Luis Nombela Franco (ESP) 34:57 &#8211; Mitral valve-in-valve &#8211; Dr. Guering Eid Lidt (MEX)

The Best of Main Arena - SOLACI-SOCIME 2022

The Best of the SOLACI-SOCIME 2022 Main Arena: Mitral Valve

During the “Mitral Valve” session (on the first day of the SOLACI-SOCIME 2022 Congress), Dr. Ignacio Amat Santos (SPA) delivered a great talk on transcatheter mitral valve replacement (TMVR). During his presentation, he discussed different scenarios for transcatheter replacement: mitral valve-in-vale, mitral valve-in-ring, mitral valve in MAC, and new devices for non-calcified native valves.&nbsp; When<a href="https://solaci.org/en/2022/08/09/the-best-of-the-solaci-socime-2022-main-arena-mitral-valve/" title="Read more" >...</a>

EuroPCR 2022 | Cambios en el daño cardíaco luego del reemplazo valvular aórtico por cirugía

EuroPCR 2022 | Changes in Cardiac Damage after Surgical Aortic Valve Replacement

This study presented at EuroPCR 2022 analyzed the PARTNER study pool and included 1974 patients with a complete echocardiogram. Surgical risk was 17.3% extreme/inoperable, 54.3% intermediate and 28.4% low. 60% received transcatheter aortic valve replacement (TAVR) and the rest surgical aortic valve replacement (SAVR).&nbsp; 6.1% of patients were in stage 0 (no damage), 14.5% were<a href="https://solaci.org/en/2022/05/19/europcr-2022-changes-in-cardiac-damage-after-surgical-aortic-valve-replacement/" title="Read more" >...</a>

Estenosis aórtica severa asintomática en añosos: ¿cuándo intervenir?

Transcatheter Edge-To-Edge Repair Is Favorable for Elderly Patients at High Surgical Risk

Mitral valve prolapse is the most frequent cause of mitral valve regurgitation and is associated to hospitalization for cardiac failure and mortality. At present, the preferred treatment for operable patients is mitral valve surgical repair. Transcatheter edge to edge repair (TEER) has shown great benefit patients at high surgical risk; however, it has not been<a href="https://solaci.org/en/2022/05/12/transcatheter-edge-to-edge-repair-is-favorable-for-elderly-patients-at-high-surgical-risk/" title="Read more" >...</a>

Is Increased Mitral Valve Gradient After MitraClip a Long-Term Prognostic Factor?

Transcatheter mitral valve repair using the edge-to-edge strategy has become a therapeutic alternative for patients with severe primary mitral valve regurgitation (MVG) who are at high or extreme surgical risk. However, both degree of residual regurgitation and gradient after the procedure should be taken into account, as in previous studies the latter was associated with<a href="https://solaci.org/en/2022/05/09/is-increased-mitral-valve-gradient-after-mitraclip-a-long-term-prognostic-factor/" title="Read more" >...</a>

Top